Studies focusing on expression analysis in CLL utilising microarrays report median purities of 88 and 90% of CD19 positive cells using DGC [3,4] though it is likely that selection occurred for samples with high purity. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.